Predictive Genetic Counseling Service Market Report 2025

The predictive genetic counseling service market size has grown rapidly in recent years. It will grow from $3.59 billion in 2024 to $3.98 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth observed during the historic period can be attributed to the rising prevalence of genetic disorders and hereditary cancers, increasing focus on early disease detection and prevention, a growing global burden of chronic diseases, greater integration of genetics in clinical decision-making, and the expanding use of predictive analytics in healthcare.

The predictive genetic counseling service market size is expected to see rapid growth in the next few years. It will grow to $5.92 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth projected for the forecast period can be attributed to the expanding role of pharmacogenomics in therapy planning, increasing public awareness of hereditary conditions, growing demand for proactive healthcare, rising genetic literacy among patients, and greater demand for family planning support. Key trends during this period include advancements in next-generation sequencing, miniaturization of diagnostic devices, development of artificial intelligence for genetic risk prediction, integration of genetic data with electronic health records, and innovations in direct-to-consumer genetic testing.

The rising investments in genetic research are expected to drive substantial growth in the predictive genetic counseling service market. Genetic research systematically investigates genes and heredity to understand how genetic traits influence biological functions and disease susceptibility. Increased funding in this sector, fueled by advances in genetic sequencing and precision medicine, is accelerating the development of targeted therapies and expanding commercially viable biomedical research. These investments also boost demand for predictive genetic counseling services by identifying new genetic markers for inherited diseases, creating a need for professionals to interpret these findings and advise individuals on health risks. For example, in December 2022, the UK government allocated $139 million (£105 million) to a research initiative exploring how whole genome sequencing can enhance early detection and treatment of rare genetic disorders in newborns, potentially benefiting thousands of infants.

Leading companies in the predictive genetic counseling market are expanding initiatives to provide free or low-cost genetic counseling, supporting early diagnosis and informed health decisions. No-cost counseling services offer consultations that help individuals understand their genetic risks and are often backed by public health programs, research initiatives, or nonprofit organizations. In May 2023, Vigil Neuroscience Inc., a US-based biotechnology firm, launched ALSPAware, offering free genetic testing and counseling for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). The program provides confidential testing, access to custom gene panels, and guidance from licensed genetic counselors, aiming to reduce misdiagnosis and improve disease management.

In February 2025, Tempus AI Inc., a US-based health technology company, acquired Ambry Genetics, a provider of predictive genetic counseling services. This acquisition strengthens Tempus AI’s ability to leverage diagnostics and data-driven insights for innovative counseling solutions, enhancing service delivery for healthcare providers, patients, and life sciences companies, and further driving the growth of the predictive genetic counseling market.

Major players in the predictive genetic counseling service market are Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Natera Inc., Tempus AI Inc., Fulgent Genetics Inc., Invitae Corporation, Berry Genomics Co. Ltd., Color Genomics Inc., Decode Genetics Inc., Myriad Genetics Inc., Genpath Diagnostics, Genomic Medical Inc., GeneDx Inc., EasyDNA, Blueprint Genetics Inc., Veritas Genetics International Ltd., Abbott Pathology, Bgi Group Ltd.

North America was the largest region in the predictive genetic counseling service market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in predictive genetic counseling service market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the predictive genetic counseling service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Predictive genetic counseling service is a specialized process in which trained professionals evaluate the likelihood of inherited genetic conditions by analyzing an individual's family history and genetic background. This service interprets genetic information to assess potential health risks, providing individuals with informed insights into their genetic predispositions.

The primary types of predictive genetic counseling services include premarital examination services, parent-child identification services, antenatal examination services, and single-gene or polygenic disease diagnosis services. Premarital examination services involve health assessments conducted before marriage to detect genetic, infectious, or chronic conditions that may affect either partner or future offspring. These services are applied to both adults and children and are utilized by end users such as hospitals, clinical laboratories, academic institutions, research organizations, and pharmaceutical companies.

The predictive genetic counseling service market research report is one of a series of new reports that provides predictive genetic counseling service market statistics, including predictive genetic counseling service industry global market size, regional shares, competitors with a predictive genetic counseling service market share, detailed predictive genetic counseling service market segments, market trends and opportunities, and any further data you may need to thrive in the predictive genetic counseling service industry. This predictive genetic counseling service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The predictive genetic counseling service market includes revenues earned by entities by providing services such as family history assessment, carrier status interpretation, inheritance pattern explanation, psychosocial support counseling, and risk reduction strategy guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.